TCM
Tekla Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $12.4M | Buy |
138,791
+15,000
| +12% | +$1.34M | 0.48% | 50 |
|
|
2023
Q1 | $13.3M | Hold |
123,791
| – | – | 0.51% | 45 |
|
|
2022
Q4 | $15.1M | Buy |
123,791
+55,997
| +83% | +$6.84M | 0.57% | 43 |
|
|
2022
Q3 | $7M | Hold |
67,794
| – | – | 0.29% | 64 |
|
|
2022
Q2 | $6.3M | Hold |
67,794
| – | – | 0.25% | 78 |
|
|
2022
Q1 | $7.96M | Hold |
67,794
| – | – | 0.28% | 73 |
|
|
2021
Q4 | $9.12M | Hold |
67,794
| – | – | 0.29% | 76 |
|
|
2021
Q3 | $10.8M | Sell |
67,794
-85,842
| -56% | -$13.7M | 0.35% | 71 |
|
|
2021
Q2 | $20.2M | Buy |
153,636
+35,300
| +30% | +$4.64M | 0.66% | 42 |
|
|
2021
Q1 | $15.3M | Buy |
118,336
+22,090
| +23% | +$2.85M | 0.52% | 52 |
|
|
2020
Q4 | $16.1M | Sell |
96,246
-29,500
| -23% | -$4.92M | 0.56% | 51 |
|
|
2020
Q3 | $19.4M | Buy |
125,746
+68,264
| +119% | +$10.5M | 0.73% | 34 |
|
|
2020
Q2 | $8.5M | Sell |
57,482
-11,850
| -17% | -$1.75M | 0.32% | 65 |
|
|
2020
Q1 | $7.81M | Hold |
69,332
| – | – | 0.35% | 58 |
|
|
2019
Q4 | $9.65M | Sell |
69,332
-7,835
| -10% | -$1.09M | 0.36% | 61 |
|
|
2019
Q3 | $7.43M | Buy |
77,167
+3,520
| +5% | +$339K | 0.32% | 62 |
|
|
2019
Q2 | $8.48M | Buy |
73,647
+12,287
| +20% | +$1.41M | 0.35% | 66 |
|
|
2019
Q1 | $7.22M | Buy |
61,360
+18,961
| +45% | +$2.23M | 0.29% | 73 |
|
|
2018
Q4 | $2.66M | Sell |
42,399
-23,315
| -35% | -$1.46M | 0.11% | 115 |
|
|
2018
Q3 | $4.66M | Buy |
65,714
+21,800
| +50% | +$1.54M | 0.17% | 97 |
|
|
2018
Q2 | $2.92M | Buy |
43,914
+37,700
| +607% | +$2.51M | 0.11% | 118 |
|
|
2018
Q1 | $406K | Buy |
+6,214
| New | +$406K | 0.02% | 176 |
|